A detailed history of Neuberger Berman Group LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 120,939 shares of IDYA stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120,939
Previous 90,409 33.77%
Holding current value
$2.68 Million
Previous $3.17 Million 20.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $927,196 - $1.31 Million
30,530 Added 33.77%
120,939 $3.83 Million
Q2 2024

Nov 14, 2024

BUY
$34.37 - $43.46 $228,697 - $289,182
6,654 Added 7.94%
90,409 $3.17 Million
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $228,697 - $289,182
6,654 Added 7.94%
90,409 $3.17 Million
Q1 2024

Nov 14, 2024

SELL
$34.2 - $47.13 $227,566 - $313,603
-6,654 Reduced 7.36%
83,755 $3.68 Million
Q1 2024

May 13, 2024

BUY
$34.2 - $47.13 $2.86 Million - $3.95 Million
83,755 New
83,755 $3.68 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.07B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.